EyeUpdate Home
Contact Us Sitemap hdr
hdr2 hdr3 hdr5
Clinical Pearls Case Studies Seminars / Lectures Books Links
sub1

 





sub2 sub3

Diabetes Update

Evaluating the Diabetic Patient

Let's go beyond the mundane, annual dilated eye examination. Every doctor reading this is quite capable of detecting macular edema, microaneurysms, intraretinal microvascular abnormalities, dot/blot hemorrhages, hard and soft exudates, vitreous hemorrhages, etc., in the diabetic patient.

The greater challenge for many of us is how to better partner with the patient's physician primarily responsible for his or her diabetic care to help prevent these ocular complications. Patients with diabetes, like patients with glaucoma, need consistent encouragement with their compliance and care.

One aspect of diabetes care that is particularly helpful is knowing the hemoglobin A1C percent concentration. This is measured as the fraction of hemoglobin that is "glycosolated hemoglobin." It is read as the percentage of hemoglobin that has glucose binding. Since the red blood cell life cycle is about 120 days (4 months), clinical testing for HbA1C provides information on the average blood glucose control over the previous four-month period. However, because of the relatively short life span (high turnover rate) of RBCs, the A1C reading is skewed to reflect blood glucose levels closest to the time the test was done. That is to say, about 50% of the A1C percentage reflects blood glucose levels over the most recent four to six-week period.

It is well established that diabetic eye disease is closely associated with the A1C fraction. Most physicians typically perform this blood test every four months. The A1C fraction in non-diabetic patients is less than 6%. The A1C percentage levels in diabetic patients commonly range from 4 to 12%. The higher the percentage over 7, the poorer the glycemic control, and the higher the likelihood of complications becomes, especially for diabetic retinopathy. In well-controlled diabetics, the A1C fraction ranges from 5% to 6.5%.

We use this barometer of glucose control to help encourage and congratulate (or admonish and warn) our patients. If the patient's A1C value (by history or obtained in your office) is 7% or higher, we take an extra minute to encourage them to work harder at their diet, exercise and medication compliance. Conversely, if their A1C is 6.5% or less, we congratulate and further encourage them in their efforts.

It is both amazing and frustrating to us that most patients we encounter have no idea what their A1C number is. Either their doctors are not taking the time to discuss the importance of this test with their patients, or perhaps the patients are simply apathetic about learning and remembering their A1C number. Whatever the case, this is a sad commentary on the state of diabetes care in America. Optometric physicians need to step in and help fill this knowledge gap whenever appropriate. This can occur on three levels:

  1. Obtain the most recent A1C readings from the patient’s physician’s office (in whatever manner you choose).

  2. Obtain the A1C level in your office using the “A1C Now” test (Metrika)—and send a copy of this to the patient’s treating physician as part of your diabetic eye evaluation report.

  3. Most importantly, take a minute to explain what hemoglobin A1C is and its importance to the patient. If the patient’s treating doctor is not doing this, it is certainly a public health service that we can, and should, provide.

Such patient care involvement elevates you from retinal evaluator to co-managing physician, which hopefully results in an enhanced level of patient care that improves their quality of life. We all need encouragement in one form or another, and our patients with diabetes often struggle with their glucose control. Whatever we can do to go the extra mile for our patients, whatever their ocular needs, should make our days in the office even more meaningful, fulfilling and rewarding.

A1C for the Optometric Office
Obtaining a random blood glucose assessment in the office is about as clinically relevant as a one-time IOP measurement. Obtaining three or four IOP measurements at different times and/or on different days is much more clinically meaningful. Likewise, being able to obtain in-office hemoglobin A1C levels would be much more clinically relevant than a spot check of the blood glucose level at that particular moment.

A new test is now available that is FDA-approved for in-home or in-office assessments of hemoglobin A1C. Just as many thousands of you already provide blood glucose measurements in your office, now you can just as easily provide state-of-the-art A1C assessment. No additional laboratory or regulatory paperwork or certification is required.

These tests are inexpensive and can be immensely helpful in the care and management of our patients with diabetes. For information on providing hemoglobin A1C testing in your office, visit www.a1cnow.com, or call 1-877-212-4968.

Metrika, the company who developed this test, also has a variety of excellent doctor and patient education materials that nicely discuss hemoglobin A1C and its testing. This is yet another way our fine profession can play a crucial role in the care of our patients with diabetes.

It is imperative that your patient's primary care physician and/or endocrinologist receive a report of your eye findings. We have developed the the following form to expedite this vital communication link.  It is yours to dowload and use at your pleasure.

One important note, many physicians (and your patients) may not be aware of your competence to perform comprehensive diabetic eye evaluations. It is crucial that your educate your patients of your abilities in this role, or their naive and well-meaning physicians may benevolently steer them to an ophthalmologist they know and trust. This occult patient tranfer ocurs regularily by well-meaning physicians who simply think they are doing their best for their patients. It is your responsibility to inform and educate your patients regarding your clinical competence. One way to "sieze the moment" is to discuss the hemoglobin A1C parameter with your patients.

PDF File - If you do not have at least the FREE version of Adobe Acrobat Reader on your computer, you will need to install the "Free Reader" onto your system, than go back and click on the form you want. If you need Acrobat Reader, just click on the button and follow the instructions for your particular computer. You will need only the "Reader" to view and print the reports.


ftr